Paediatric pharmacokinetics and drug doses.
作者信息
O'Hara Kate
机构信息
Pharmacist and PhD candidate, Discipline of Clinical Pharmacology and Toxicology, School of Medicine and Public Health, University of Newcastle, New South Wales.
出版信息
Aust Prescr. 2016 Dec;39(6):208-210. doi: 10.18773/austprescr.2016.071. Epub 2016 Dec 5.
Abstract
摘要
相似文献
1
Paediatric pharmacokinetics and drug doses.
Aust Prescr. 2016 Dec;39(6):208-210. doi: 10.18773/austprescr.2016.071. Epub 2016 Dec 5.
2
[Pharmacokinetic and pharmacodynamic modelling in paediatric drug development with a focus on physiology-based pharmacokinetic simulations].
Z Evid Fortbild Qual Gesundhwes. 2019 May;141-142:66-73. doi: 10.1016/j.zefq.2019.03.003. Epub 2019 Mar 29.
3
Cyclosporin pharmacokinetics in paediatric transplant recipients.
Clin Pharmacokinet. 1997 Jun;32(6):481-95. doi: 10.2165/00003088-199732060-00004.
4
Minutes from the round table held in Paris on July 6, 2007: 'Contribution of modelling in the paediatric drug development'.
Fundam Clin Pharmacol. 2008 Dec;22(6):609-12. doi: 10.1111/j.1472-8206.2008.00653.x.
5
Paediatrics and medication administration. Some practical issues.
Aust Nurs J. 1998 Nov;6(5):suppl 1-4.
6
Can positron emission tomography facilitate paediatric drug development?
Fundam Clin Pharmacol. 2008 Dec;22(6):595-8. doi: 10.1111/j.1472-8206.2008.00650.x.
7
Physiology-based pharmacokinetics of caspofungin for adults and paediatrics.
Pharm Res. 2015 Jun;32(6):2029-37. doi: 10.1007/s11095-014-1595-9. Epub 2014 Dec 19.
8
Practical pharmacokinetics: what do you really need to know?
Arch Dis Child Educ Pract Ed. 2015 Feb;100(1):37-43. doi: 10.1136/archdischild-2013-304555. Epub 2014 Aug 13.
9
Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics.
Clin Pharmacokinet. 2017 Jan;56(1):77-90. doi: 10.1007/s40262-016-0430-3.
10
Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.
Br J Clin Pharmacol. 2015 Nov;80(5):1197-207. doi: 10.1111/bcp.12710. Epub 2015 Sep 5.
引用本文的文献
1
Drug-Induced Liver Injury-Pharmacological Spectrum Among Children.
Int J Mol Sci. 2025 Feb 25;26(5):2006. doi: 10.3390/ijms26052006.
2
Drug-related problems among pediatric intensive care units: prevalence, risk factors, and clinical pharmacists' interventions.
BMC Pediatr. 2024 Nov 8;24(1):714. doi: 10.1186/s12887-024-05185-0.
3
Extracellular vesicles as the next-generation modulators of pharmacokinetics and pharmacodynamics of medications and their potential as adjuvant therapeutics.
Clin Transl Med. 2024 Aug;14(8):e70002. doi: 10.1002/ctm2.70002.
4
A Comprehensive Review on the Role of Melatonin's Anesthetic Applications in Pediatric Care.
Cureus. 2024 May 18;16(5):e60575. doi: 10.7759/cureus.60575. eCollection 2024 May.
5
An Assessment of Medication Errors Among Pediatric Patients in Three Hospitals in Freetown Sierra Leone: Findings and Implications for a Low-Income Country.
Pediatric Health Med Ther. 2024 Mar 29;15:145-158. doi: 10.2147/PHMT.S451453. eCollection 2024.
6
Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies.
Curr Rheumatol Rep. 2024 Jun;26(6):214-221. doi: 10.1007/s11926-024-01145-w. Epub 2024 Mar 11.
7
Pediatric Market Access: A Qualitative Study.
Ther Innov Regul Sci. 2024 Mar;58(2):336-346. doi: 10.1007/s43441-023-00601-6. Epub 2024 Jan 3.
8
Off-Label Prescribing in Pediatric Population-Literature Review for 2012-2022.
Pharmaceutics. 2023 Nov 21;15(12):2652. doi: 10.3390/pharmaceutics15122652.
9
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study.
J Clin Med. 2023 Nov 30;12(23):7447. doi: 10.3390/jcm12237447.
10
Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review.
Front Pharmacol. 2023 Sep 19;14:1267294. doi: 10.3389/fphar.2023.1267294. eCollection 2023.
本文引用的文献
1
Vancomycin dosing in children: what is the question?
Arch Dis Child. 2013 Dec;98(12):994-7. doi: 10.1136/archdischild-2013-304169. Epub 2013 Aug 16.
2
Neonatal clinical pharmacology.
Paediatr Anaesth. 2014 Jan;24(1):30-8. doi: 10.1111/pan.12176. Epub 2013 Apr 26.
3
Extra-uterine renal growth in preterm infants: oligonephropathy and prematurity.
Pediatr Nephrol. 2013 Sep;28(9):1791-6. doi: 10.1007/s00467-013-2462-3. Epub 2013 Apr 4.
4
Population pharmacokinetic analysis during the first 2 years of life: an overview.
Clin Pharmacokinet. 2012 Dec;51(12):787-98. doi: 10.1007/s40262-012-0015-8.
5
Developmental pharmacology: neonates are not just small adults..
Acta Clin Belg. 2008 Jan-Feb;63(1):16-24. doi: 10.1179/acb.2008.003.
6
Prediction of drug clearance in children from adults: a comparison of several allometric methods.
Br J Clin Pharmacol. 2006 May;61(5):545-57. doi: 10.1111/j.1365-2125.2006.02622.x.
7
Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?
Clin Pharmacokinet. 2006;45(1):1-11. doi: 10.2165/00003088-200645010-00001.
8
How children's responses to drugs differ from adults.
Br J Clin Pharmacol. 2005 Jun;59(6):670-3. doi: 10.1111/j.1365-2125.2005.02445.x.
9
Drug toxicity in the neonate.
Biol Neonate. 2004;86(4):218-21. doi: 10.1159/000079656. Epub 2004 Jul 8.
10
Dose estimation for children.
Br J Clin Pharmacol. 2003 Nov;56(5):489-93. doi: 10.1046/j.1365-2125.2003.01901.x.
Zotero 插件